GR3031981T3 - Halichondrins: Cytotoxic polyether macrolides. - Google Patents

Halichondrins: Cytotoxic polyether macrolides.

Info

Publication number
GR3031981T3
GR3031981T3 GR990403074T GR990403074T GR3031981T3 GR 3031981 T3 GR3031981 T3 GR 3031981T3 GR 990403074 T GR990403074 T GR 990403074T GR 990403074 T GR990403074 T GR 990403074T GR 3031981 T3 GR3031981 T3 GR 3031981T3
Authority
GR
Greece
Prior art keywords
cytotoxic
halichondrins
macrolides
polyether
chem
Prior art date
Application number
GR990403074T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3031981T3 publication Critical patent/GR3031981T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Dental Preparations (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990403074T 1992-03-23 1999-11-29 Halichondrins: Cytotoxic polyether macrolides. GR3031981T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929206244A GB9206244D0 (en) 1992-03-23 1992-03-23 Cytotoxic compound from a marine sponge

Publications (1)

Publication Number Publication Date
GR3031981T3 true GR3031981T3 (en) 2000-03-31

Family

ID=10712627

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403074T GR3031981T3 (en) 1992-03-23 1999-11-29 Halichondrins: Cytotoxic polyether macrolides.

Country Status (12)

Country Link
US (1) US5786492A (el)
EP (1) EP0572109B1 (el)
JP (1) JP3168098B2 (el)
AT (1) ATE184009T1 (el)
AU (1) AU671818B2 (el)
CA (1) CA2092108A1 (el)
DE (1) DE69326192T2 (el)
DK (1) DK0572109T3 (el)
ES (1) ES2138993T3 (el)
GB (1) GB9206244D0 (el)
GR (1) GR3031981T3 (el)
ZA (1) ZA932061B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
JP4454151B2 (ja) * 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
SI2522663T1 (sl) 2004-06-03 2015-08-31 Eisai R&D Management Co., Ltd. Vmesne spojine za pripravo halihondrina B
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
CA2720632C (en) 2008-04-04 2016-12-20 Eisai R&D Management Co., Ltd. Halichondrin b analogs
CN102149363A (zh) * 2008-07-15 2011-08-10 巴斯夫公司 二氧化氯的施用方法、系统和装置
RU2579511C2 (ru) 2010-01-26 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные фуро[3,2-в]пирана, применимые в синтезе аналогов
BR112016009452B1 (pt) 2013-11-04 2022-06-07 Eisai R&D Management Co., Ltd Métodos de preparar intermediários na síntese de eribulina, métodos de preparar eribulina e mesilato de eribulina, e compostos intermediários
EP3077399B1 (en) 2013-12-06 2019-02-20 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
CN108601760A (zh) 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
KR102404629B1 (ko) 2016-06-30 2022-06-02 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 중간체
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SMT202200455T1 (it) 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019099646A1 (en) 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof
WO2019097073A1 (en) 2017-11-20 2019-05-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
IL275729B2 (en) 2018-01-03 2023-09-01 Eisai R&D Man Co Ltd Prins reaction and compounds useful in the synthesis of helicondrin macrolides and their analogs

Also Published As

Publication number Publication date
DE69326192D1 (de) 1999-10-07
EP0572109B1 (en) 1999-09-01
ZA932061B (en) 1993-10-19
US5786492A (en) 1998-07-28
GB9206244D0 (en) 1992-05-06
JPH06122687A (ja) 1994-05-06
DE69326192T2 (de) 2000-05-04
CA2092108A1 (en) 1993-09-24
AU3543393A (en) 1993-09-30
JP3168098B2 (ja) 2001-05-21
DK0572109T3 (da) 2000-03-27
AU671818B2 (en) 1996-09-12
ES2138993T3 (es) 2000-02-01
EP0572109A1 (en) 1993-12-01
ATE184009T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
GR3031981T3 (en) Halichondrins: Cytotoxic polyether macrolides.
IL89921A (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
AU5162796A (en) Novel peptide derivatives
ITRM940324A0 (it) "formulazioni galenione contenenti macrolidi".
PL324502A1 (en) Pharmaceutic compositions
TW269678B (el)
AU579232B2 (en) Novel 1,2-benzisoxazol-3-YL and 1,2-benzisothiazol-3-YL derivatives
IL119118A0 (en) 9-Ú(Haloacyl) amido¾-7- (substituted)-6- demethyl-6-deoxytetracycline intermediates
GB9321855D0 (en) 1,4-piperazine derivatives
AU4419193A (en) Synthesis of 1,4,7-triazacyclononane derivatives
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
GR3031521T3 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug.
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
HUT71398A (en) Derivatives of dolastatin
TW257750B (el)
WO1995016430A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
HUP9600498A3 (en) Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same
CA2112240C (en) IMAGE-FORMING MATERIALS, INCLUDING COLORING SUBSTANCES COMPRISING TWO OR MORE NUCLEAR NUCLEAR GROUPS 1.3 OR MORE AND TWO OR MORE CHROMATIC FUNCTIONAL GROUPS
IL107017A0 (en) Thiomarinol derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
AU1174588A (en) Anticonvulsant agents
TW218011B (el)
AU6923894A (en) 1,2,5-thiadiazole derivatives, their preparation and use
AU6506594A (en) 3-phenyl-1,2,5,6-tetrahydropyridine derivatives as sedatives